In the last three months, 9 analysts have published ratings on Legend Biotech (NASDAQ:LEGN), offering a diverse range of perspectives from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.0, a high estimate of $86.00, and a low estimate of $73.00. This current average reflects an increase of 1.13% from the previous average price target of $78.12.

Interpreting Analyst Ratings: A Closer Look

In examining recent analyst actions, we gain...